Corporativo Fragua S.A.B. de C.V Market Cap ($2.29 Billion)
Market Cap & Net Worth: Corporativo Fragua S.A.B. de C.V (FRAGUAB)
Corporativo Fragua S.A.B. de C.V market cap. Corporativo Fragua S.A.B. de C.V (MX:FRAGUAB) has a market capitalization of $2.29 Billion (MX$39.71 Billion) as of November 1, 2026. Listed on the MX stock exchange, this Mexico-based company holds position #5502 globally and #69 in its home market, demonstrating a -0.52% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Corporativo Fragua S.A.B. de C.V's stock price MX$414.80 by its total outstanding shares 95741677 (95.74 Million). Also see FRAGUAB cash flow conversion for how efficiently the company converts equity into cash flow.
Corporativo Fragua S.A.B. de C.V Market Cap History (2015–2026)
Corporativo Fragua S.A.B. de C.V market cap history from 2015 to 2026. Data shows growth from $1.17 Billion to $2.29 Billion (6.74% CAGR). Check latest Corporativo Fragua S.A.B. de C.V stock price today for real-time trading data and today's change.
Corporativo Fragua S.A.B. de C.V Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Corporativo Fragua S.A.B. de C.V's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Corporativo Fragua S.A.B. de C.V equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.03x
Corporativo Fragua S.A.B. de C.V's market cap is 0.03 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.76x
Corporativo Fragua S.A.B. de C.V's market cap is 0.76 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.17 Billion | $35.79 Billion | $973.57 Million | 0.03x | 1.20x |
| 2016 | $1.27 Billion | $40.57 Billion | $1.10 Billion | 0.03x | 1.15x |
| 2017 | $1.15 Billion | $46.67 Billion | $1.34 Billion | 0.02x | 0.86x |
| 2018 | $1.30 Billion | $53.35 Billion | $1.53 Billion | 0.02x | 0.85x |
| 2019 | $1.20 Billion | $61.88 Billion | $1.71 Billion | 0.02x | 0.70x |
| 2020 | $1.33 Billion | $73.31 Billion | $2.03 Billion | 0.02x | 0.66x |
| 2021 | $1.74 Billion | $84.79 Billion | $2.62 Billion | 0.02x | 0.66x |
| 2022 | $1.85 Billion | $97.92 Billion | $3.18 Billion | 0.02x | 0.58x |
| 2023 | $2.71 Billion | $109.37 Billion | $4.50 Billion | 0.02x | 0.60x |
| 2024 | $3.75 Billion | $120.24 Billion | $4.90 Billion | 0.03x | 0.76x |
Competitor Companies of FRAGUAB by Market Capitalization
Companies near Corporativo Fragua S.A.B. de C.V in the global market cap rankings as of November 1, 2026. Also see FRAGUAB total assets for a full breakdown of the balance sheet.
Key companies related to Corporativo Fragua S.A.B. de C.V by market ranking:
- JD HEALTH INTL LTD (F:8ZN): Ranked #1867 globally with a market cap of $12.04 Billion USD ( €10.30 Billion EUR).
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #2108 globally with a market cap of $10.37 Billion USD.
- ALIB.HL.INF.TEC.UNSP.ADR (F:TWYA): Ranked #2442 globally with a market cap of $8.42 Billion USD ( €7.20 Billion EUR).
- Raia Drogasil S.A (SA:RADL3): Ranked #3350 globally with a market cap of $5.22 Billion USD ( R$26.61 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1867 | JD HEALTH INTL LTD | F:8ZN | $12.04 Billion | €4.30 |
| #2108 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $10.37 Billion | $11.98 |
| #2442 | ALIB.HL.INF.TEC.UNSP.ADR | F:TWYA | $8.42 Billion | €8.95 |
| #3350 | Raia Drogasil S.A | SA:RADL3 | $5.22 Billion | R$15.22 |
Market Capitalization of Corporativo Fragua S.A.B. de C.V (2015–2026)
Market capitalization of Corporativo Fragua S.A.B. de C.V from 2015 to today. Between 2015 and today, Corporativo Fragua S.A.B. de C.V's market cap moved from $1.17 Billion to $ 2.29 Billion, with a yearly change of 6.74%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | MX$2.29 Billion | -25.26% |
| 2025 | MX$3.06 Billion | -18.38% |
| 2024 | MX$3.75 Billion | +38.38% |
| 2023 | MX$2.71 Billion | +46.45% |
| 2022 | MX$1.85 Billion | +6.42% |
| 2021 | MX$1.74 Billion | +30.31% |
| 2020 | MX$1.33 Billion | +11.50% |
| 2019 | MX$1.20 Billion | -8.24% |
| 2018 | MX$1.30 Billion | +13.25% |
| 2017 | MX$1.15 Billion | -9.52% |
| 2016 | MX$1.27 Billion | +8.89% |
| 2015 | MX$1.17 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Corporativo Fragua S.A.B. de C.V was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.29 Billion USD |
| MoneyControl | $2.29 Billion USD |
| MarketWatch | $2.29 Billion USD |
| marketcap.company | $2.29 Billion USD |
| Reuters | $2.29 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Corporativo Fragua S.A.B. de C.V
Corporativo Fragua, S.A.B. de C.V., together with its subsidiaries, operates pharmacy stores in Mexico. The company purchases and sells medicine products, perfumes, photography equipment, household goods, food, miscellaneous items, and others. It is also involved in the provision of maintenance and surveillance services, and medical services; operation service of distribution centers; management,… Read more